Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Servant

Showing results (111-120 of 129) with videos related to

Pageof 13
Sort By:
JCI Insight|September 22, 2017
Adrenal GIPR expression and chromosome 19q13 microduplications in GIP-dependent Cushing's syndromeAnne-Lise Lecoq, Constantine A Stratakis, Say Viengchareun, et al.
Nature Communications|October 20, 2023
Imaging and multi-omics datasets converge to define different neural progenitor origins for ATRT-SHH subgroupsMaría-Jesús Lobón-Iglesias, Mamy Andrianteranagna, Zhi-Yan Han, et al.
Molecular Oncology|April 10, 2022
Human papilloma virus integration sites and genomic signatures in head and neck squamous cell carcinomaJuliette Mainguené, Sophie Vacher, Maud Kamal, et al.
Cancer Cell|November 12, 2019
Clonally Expanded T Cells Reveal Immunogenicity of Rhabdoid TumorsAmaury Leruste, Jimena Tosello, Rodrigo Nalio Ramos, et al.
The Lancet Regional Health. Europe|November 24, 2025
Management and survival of patients with cancer of unknown primary discussed by a French national multidisciplinary tumour board: a retrospective analysisCélia Dupain, Nicolas Jacquin, Aurélien Latouche, et al.
Nature|April 26, 2023
A druggable copper-signalling pathway that drives inflammationStéphanie Solier, Sebastian Müller, Tatiana Cañeque, et al.
Nature Communications|January 27, 2026
Ether lipids influence cancer cell fate by modulating iron uptakeRyan P Mansell, Sebastian Müller, Jia-Shu Yang, et al.
Nature Communications|April 29, 2024
VC-resist glioblastoma cell state: vessel co-option as a key driver of chemoradiation resistanceCathy Pichol-Thievend, Oceane Anezo, Aafrin M Pettiwala, et al.
Nature Cancer|June 30, 2025
Efficacy of pembrolizumab and vorinostat combination in patients with recurrent and/or metastatic squamous cell carcinomas: a phase 2 basket trialEdith Borcoman, Bastien Cabarrou, Miguel Francisco, et al.
Nature|September 7, 2022
Genomics to select treatment for patients with metastatic breast cancerFabrice Andre, Thomas Filleron, Maud Kamal, et al.
Pageof 13

Showing results (111-120 of 129) with videos related to

Sort By:
Pageof 13
JCI Insight|September 22, 2017
Adrenal GIPR expression and chromosome 19q13 microduplications in GIP-dependent Cushing's syndromeAnne-Lise Lecoq, Constantine A Stratakis, Say Viengchareun, et al.
Nature Communications|October 20, 2023
Imaging and multi-omics datasets converge to define different neural progenitor origins for ATRT-SHH subgroupsMaría-Jesús Lobón-Iglesias, Mamy Andrianteranagna, Zhi-Yan Han, et al.
Molecular Oncology|April 10, 2022
Human papilloma virus integration sites and genomic signatures in head and neck squamous cell carcinomaJuliette Mainguené, Sophie Vacher, Maud Kamal, et al.
Cancer Cell|November 12, 2019
Clonally Expanded T Cells Reveal Immunogenicity of Rhabdoid TumorsAmaury Leruste, Jimena Tosello, Rodrigo Nalio Ramos, et al.
The Lancet Regional Health. Europe|November 24, 2025
Management and survival of patients with cancer of unknown primary discussed by a French national multidisciplinary tumour board: a retrospective analysisCélia Dupain, Nicolas Jacquin, Aurélien Latouche, et al.
Nature|April 26, 2023
A druggable copper-signalling pathway that drives inflammationStéphanie Solier, Sebastian Müller, Tatiana Cañeque, et al.
Nature Communications|January 27, 2026
Ether lipids influence cancer cell fate by modulating iron uptakeRyan P Mansell, Sebastian Müller, Jia-Shu Yang, et al.
Nature Communications|April 29, 2024
VC-resist glioblastoma cell state: vessel co-option as a key driver of chemoradiation resistanceCathy Pichol-Thievend, Oceane Anezo, Aafrin M Pettiwala, et al.
Nature Cancer|June 30, 2025
Efficacy of pembrolizumab and vorinostat combination in patients with recurrent and/or metastatic squamous cell carcinomas: a phase 2 basket trialEdith Borcoman, Bastien Cabarrou, Miguel Francisco, et al.
Nature|September 7, 2022
Genomics to select treatment for patients with metastatic breast cancerFabrice Andre, Thomas Filleron, Maud Kamal, et al.
Pageof 13